Zoom Logo

Winship ASCO 2020 Research Updates - Shared screen with speaker view
Javier De Jesus
22:27
Hello and welcome everyone to our webinar, Winship at ASCO 2020!
Javier De Jesus
22:56
Please use the Q&A feature if you have questions for either Dr. Ramalingam or Dr. Lonial.
Javier De Jesus
25:11
ASCO abstract link: Nivolumab + ipilimumab versus platinum-doublet chemotherapy as first-line treatment for advanced non-small cell lung cancer: Three-year update from CheckMate 227 https://meetinglibrary.asco.org/record/184651/abstract
Javier De Jesus
31:51
ASCO abstract link: Pivotal DREAMM-2 study: Single-agent belantamab mafodotin (GSK2857916) in patients with relapsed/refractory multiple myeloma (RRMM) refractory to proteasome inhibitors (PIs), immunomodulatory agents, and refractory and/or intolerant to anti-CD38 monoclonal antibodies (mAbs) https://meetinglibrary.asco.org/record/186180/abstract
Javier De Jesus
32:32
ASCO abstract link: DREAMM-6: Safety and tolerability of belantamab mafodotin in combination with bortezomib/dexamethasone in relapsed/refractory multiple myeloma https://meetinglibrary.asco.org/record/186921/abstract
Javier De Jesus
33:20
ASCO abstract link: Updated analysis of a phase I/II study of venetoclax in combination with daratumumab and dexamethasone, +/- bortezomib, in patients with relapsed/refractory multiple myeloma https://meetinglibrary.asco.org/record/187561/abstract
Javier De Jesus
36:09
ASCO plenary session: Carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) for initial therapy of newly diagnosed multiple myeloma (NDMM): Results of ENDURANCE (E1A11) phase III trial https://meetinglibrary.asco.org/record/186906/abstract
Javier De Jesus
38:06
Reminder, please use the Q&A feature if you have questions for either Dr. Ramalingam or Dr. Lonial.
Javier De Jesus
38:54
ASCO abstract link: Phase I trial of lorlatinib in patients with ALK-driven refractory or relapsed neuroblastoma: A New Approaches to Neuroblastoma Consortium study https://meetinglibrary.asco.org/record/185854/abstract
Javier De Jesus
39:49
ASCO abstract link: Concurrent cetuximab (CTX) and nivolumab (NIVO) in patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): Results of phase II study https://meetinglibrary.asco.org/record/184661/abstract
Javier De Jesus
40:59
ASCO abstract link: YAP1 positive small-cell lung cancer subtype is associated with the T-cell inflamed gene expression profile and confers good prognosis and long term survival https://meetinglibrary.asco.org/record/187452/abstract
Javier De Jesus
41:37
ASCO abstract link: A cost analysis of managing cancer-related pain among hospitalized US cancer patients https://meetinglibrary.asco.org/record/187842/abstract
Javier De Jesus
42:19
Please use the Q&A feature if you have questions for either Dr. Ramalingam or Dr. Lonial.
Javier De Jesus
43:22
ASCO abstract link: Effect of informational charts on patient understanding of nontherapeutic research procedures in phase I trials https://meetinglibrary.asco.org/record/190030/abstract
Javier De Jesus
48:23
Learn more about our clinical research by visiting our website at https://winshipcancer.emory.edu